Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can changing dialysis times save Patients' legs?

NCT ID NCT07479888

Knowledge-focused Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 60 adults on long-term dialysis to see if the schedule of dialysis sessions affects blood flow to the legs. Some patients did standard 4-hour sessions three times a week, while others did shorter 2-hour sessions six times a week. The goal was to find out which schedule better prevents dangerous drops in leg blood pressure during treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors choose a dialysis schedule that reduces the risk of serious leg complications in kidney patients.
What could go wrong
This is a small, completed study with only 60 participants. Results may not apply to all dialysis patients, and the benefit may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

60 people

The number who actually took part.

Started

Dec 2021

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients undergoing chronic hemodialysis

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient must be an adult (aged 18 years or older) * Must have been on chronic hemodialysis for at least 3 months * Must be willing to undergo one week of daily hemodialysis to assess its clinical benefit * Must have read and understood the information letter and agree to participate in the study Exclusion Criteria: * Bilateral amputation including the big toes * Hemodynamic instability defined by a peridialytic blood pressure drop of more than 50% of sessions * Patient undergoing acute hemodialysis * Contraindication to either of the two dialysis modalities * Patient not wishing to undergo daily hemodialysis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dialysis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

end stage renal failure wild type ABeta2M amyloidosis limb ischemia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dialysis

Contacts and locations

Locations

  • University Rouen Hospital

    Rouen, 76031, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.